FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031939751> ?p ?o ?g. }

• W2031939751 endingPage "e160" @default.
• W2031939751 startingPage "e155" @default.
• W2031939751 abstract "Single agent epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) have demonstrated reproducible response rates of 5–15% in treatment of squamous cell carcinomas of the head and neck (SCCHN). The subset of patients that benefits most from these agents remains unknown. We reviewed individual patient data from five clinical trials of erlotinib, lapatinib, or gefitinib to determine if there are clinical characteristics that are associated with clinical benefit defined as complete response (CR), partial response (PR), and stable disease (SD) >4 months. Secondary endpoints included progression-free survival (PFS) and overall survival (OS). Three-hundred and nineteen subjects were included. Observed responses were: 1% CR, 6% PR, 24% SD >4 months, 18% SD <4 months, 45% progressive disease (PD), 7% not evaluable (NE). The median OS was 6.4 months and the median PFS was 2.7 months. The most common toxicities observed were rash (grade 1 in 37%, grade 2 in 33%, grade 3+ in 6%) and diarrhea (grade 1 in 30%, grade 2 in 10%, grade 3+ in 5%). Performance status (PS) (p = 0.04), older age (p = 0.02), and development of rash (p < 0.01), diarrhea (p = 0.03), or oral side effects (p = 0.02) were independently associated with clinical benefit. Older age, better PS, and development of rash were associated with longer PFS and OS. Clinical parameters that appear to predict response to EGFR TKI include PS and age. EGFR mechanistic toxicities that develop during therapy are also highly associated with benefit and suggest a relationship between drug exposure and outcome." @default.
• W2031939751 created "2016-06-24" @default.
• W2031939751 creator A5063904421 @default.
• W2031939751 creator A5066578904 @default.
• W2031939751 creator A5067324005 @default.
• W2031939751 creator A5070574602 @default.
• W2031939751 creator A5082413734 @default.
• W2031939751 creator A5086909430 @default.
• W2031939751 date "2009-10-01" @default.
• W2031939751 modified "2023-10-14" @default.
• W2031939751 title "Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck" @default.
• W2031939751 cites W1583948349 @default.
• W2031939751 cites W1998085563 @default.
• W2031939751 cites W1998322093 @default.
• W2031939751 cites W2000949271 @default.
• W2031939751 cites W2041166427 @default.
• W2031939751 cites W2072435700 @default.
• W2031939751 cites W2081725454 @default.
• W2031939751 cites W2096560531 @default.
• W2031939751 cites W2097584581 @default.
• W2031939751 cites W2103134643 @default.
• W2031939751 cites W2108760602 @default.
• W2031939751 cites W2120365528 @default.
• W2031939751 cites W2149412903 @default.
• W2031939751 cites W2153607474 @default.
• W2031939751 cites W2155946891 @default.
• W2031939751 cites W2242774787 @default.
• W2031939751 cites W2247923872 @default.
• W2031939751 cites W2317368883 @default.
• W2031939751 cites W3041047318 @default.
• W2031939751 doi "https://doi.org/10.1016/j.oraloncology.2009.05.637" @default.
• W2031939751 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2749898" @default.
• W2031939751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19586795" @default.
• W2031939751 hasPublicationYear "2009" @default.
• W2031939751 type Work @default.
• W2031939751 sameAs 2031939751 @default.
• W2031939751 citedByCount "44" @default.
• W2031939751 countsByYear W20319397512012 @default.
• W2031939751 countsByYear W20319397512013 @default.
• W2031939751 countsByYear W20319397512014 @default.
• W2031939751 countsByYear W20319397512015 @default.
• W2031939751 countsByYear W20319397512016 @default.
• W2031939751 countsByYear W20319397512017 @default.
• W2031939751 countsByYear W20319397512018 @default.
• W2031939751 countsByYear W20319397512019 @default.
• W2031939751 countsByYear W20319397512020 @default.
• W2031939751 countsByYear W20319397512021 @default.
• W2031939751 countsByYear W20319397512022 @default.
• W2031939751 crossrefType "journal-article" @default.
• W2031939751 hasAuthorship W2031939751A5063904421 @default.
• W2031939751 hasAuthorship W2031939751A5066578904 @default.
• W2031939751 hasAuthorship W2031939751A5067324005 @default.
• W2031939751 hasAuthorship W2031939751A5070574602 @default.
• W2031939751 hasAuthorship W2031939751A5082413734 @default.
• W2031939751 hasAuthorship W2031939751A5086909430 @default.
• W2031939751 hasBestOaLocation W20319397512 @default.
• W2031939751 hasConcept C121608353 @default.
• W2031939751 hasConcept C126322002 @default.
• W2031939751 hasConcept C143998085 @default.
• W2031939751 hasConcept C2777329042 @default.
• W2031939751 hasConcept C2778087573 @default.
• W2031939751 hasConcept C2778570526 @default.
• W2031939751 hasConcept C2778822529 @default.
• W2031939751 hasConcept C2779134260 @default.
• W2031939751 hasConcept C2779438470 @default.
• W2031939751 hasConcept C2779786085 @default.
• W2031939751 hasConcept C2780580887 @default.
• W2031939751 hasConcept C530470458 @default.
• W2031939751 hasConcept C535046627 @default.
• W2031939751 hasConcept C71924100 @default.
• W2031939751 hasConcept C90924648 @default.
• W2031939751 hasConceptScore W2031939751C121608353 @default.
• W2031939751 hasConceptScore W2031939751C126322002 @default.
• W2031939751 hasConceptScore W2031939751C143998085 @default.
• W2031939751 hasConceptScore W2031939751C2777329042 @default.
• W2031939751 hasConceptScore W2031939751C2778087573 @default.
• W2031939751 hasConceptScore W2031939751C2778570526 @default.
• W2031939751 hasConceptScore W2031939751C2778822529 @default.
• W2031939751 hasConceptScore W2031939751C2779134260 @default.
• W2031939751 hasConceptScore W2031939751C2779438470 @default.
• W2031939751 hasConceptScore W2031939751C2779786085 @default.
• W2031939751 hasConceptScore W2031939751C2780580887 @default.
• W2031939751 hasConceptScore W2031939751C530470458 @default.
• W2031939751 hasConceptScore W2031939751C535046627 @default.
• W2031939751 hasConceptScore W2031939751C71924100 @default.
• W2031939751 hasConceptScore W2031939751C90924648 @default.
• W2031939751 hasIssue "10" @default.
• W2031939751 hasLocation W20319397511 @default.
• W2031939751 hasLocation W20319397512 @default.
• W2031939751 hasLocation W20319397513 @default.
• W2031939751 hasLocation W20319397514 @default.
• W2031939751 hasOpenAccess W2031939751 @default.
• W2031939751 hasPrimaryLocation W20319397511 @default.
• W2031939751 hasRelatedWork W1997605441 @default.
• W2031939751 hasRelatedWork W2015874289 @default.
• W2031939751 hasRelatedWork W2037581548 @default.
• W2031939751 hasRelatedWork W2120200191 @default.
• W2031939751 hasRelatedWork W2184487997 @default.

• next